Dimethaid lines up $50-million credit line

Article Abstract:

Dimethaid Research Inc. has received a $50-million equity line of credit with Acqua Wellington North American Equities Fund Ltd., a Hong Kong-based investment banking company. During the 13 months of the contract, Dimethaid can tap the credit line in up to 10 installments and sell stock to Acqua at a 20-day average price of its stock on the Toronto Stock Exchange.

United States, Hong Kong, Investment Offices, Investment Companies, Open-End Investment Funds, Use of Funds, Dimethaid Research Inc., Acqua Wellington North American Equities Fund Ltd.

---

Biotech issues attract investors

Article Abstract:

In the first half of the year 2000, the biotechnology sector raised $1.57-billion (Canadian) of equity and debt, a 40% increase from 1999. In June of 2000, Axcan Pharma Inc. won commitments from New York investors to sell $40-million of stock.

Sales, profits & dividends, Forecasts, trends, outlooks, Statistical Data Included, Biotechnology industry, Biotechnology industries, AXP, Axcan Pharma Inc.

---

Drug Royalty opts out of Reo Pro deal

Article Abstract:

Drug Royalty Corporation Inc. backs out of deal to purchase a $27-million interest in royalties of the blood clotting drug ReoPro, citing failed legal issues.

Acquisitions & mergers, Mergers, acquisitions and divestments, Drug Royalty Corporation Inc., DRI, ReoPro (Medication)

Similar abstracts:

• Abstracts: Royal unit struggles for settlement. OSC, Royal unit close to a deal
• Abstracts: The unknown billionaire. For developer, a boulevard of golden dreams. Popcorn wants marketers to put their faith in her
• Abstracts: Mackenzie launches international stock fund. Sceptre Equity Growth hits a rough patch
• Abstracts: U.S. chains would buy Hollinger papers. Brookfield to buy up subsidaries' shares. Brookfield boosts presence in U.S
• Abstracts: Air Canada pilots poised to strike. Air Canada, union ask Ottawa to name mediator

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.